# US 2003/0225159 A1 · Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as AIDS

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0225159 A1
- Document ID: US20030225159A1
- Status: Published application
- Kind: A1
- Application number: 10/335,737
- Filed: 2003-01-03
- Published: 2003-12-04
- Earliest claimed: 2002-01-03
- Assignees: Herbal 2000, LLC.
- Inventors: Getachew Demssie; Seifu M. Belay
- Web page: https://patentgrep.com/patent/US20030225159A1

## CPC

- A61K 31/235: having an aromatic ring attached to a carboxyl group
- A61K 36/00: Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines {(antigens from pollen A61K39/36)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as acquired immunodeficiency syndrome (AIDS) includes a glycol derivative. More specifically, the glycol derivative includes diethylene glycol dibenzoate.

## Claims

### Claim 1

A method for controlling replication of an immunodeficiency virus, comprising:
exposing a cell infected with an immunodeficiency virus to a compound; and
wherein the compound comprises a glycol derivative.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
the cell comprises a lymphocyte.

### Claim 3 (depends on 2)

The method of claim 2, wherein:
the immunodeficiency virus comprises a human immunodeficiency virus (HIV).

### Claim 4 (depends on 3)

The method of claim 3, wherein:
the compound comprises diethylene glycol dibenzoate.

### Claim 5 (depends on 1)

The method of claim 1, wherein:
the cell comprises a CD4+T cell.

### Claim 6

A method for the prophylaxis or treatment of an immunodeficiency condition, comprising:
administering to a subject in need thereof a compound including a glycol derivative.

### Claim 7 (depends on 6)

The method of claim 6, wherein:
the glycol derivative comprises diethylene glycol dibenzoate.

### Claim 8 (depends on 7)

The method of claim 7, wherein:
the immunodeficiency condition comprises acquired immunodeficiency syndrome (AIDS).

### Claim 9

A method for the prophylaxis or treatment of an infection caused by an immunodeficiency virus, comprising:
administering to a subject in need thereof a compound including a glycol derivative.

### Claim 10 (depends on 9)

The method of claim 9, wherein:
the glycol derivative comprises diethylene glycol dibenzoate.

### Claim 11 (depends on 10)

The method of claim 10, wherein:
the immunodeficiency virus comprises a human immunodeficiency virus (HIV).

### Claim 12 (depends on 11)

The method of claim 11, wherein:
the infection comprises acquired immunodeficiency virus syndrome (AIDS).

### Claim 13

A pharmaceutical compound for the prophylaxis or treatment of acquired immunodeficiency syndrome (AIDS), comprising a glycol derivative.

### Claim 14 (depends on 13)

The pharmaceutical compound of claim 13, wherein the glycol derivative comprises diethylene glycol dibenzoate.

### Claim 15

An herbal extract for the prophylaxis or treatment of acquired immunodeficiency syndrome (AIDS), comprising a glycol derivative.

### Claim 16 (depends on 15)

The herbal extract of claim 15, wherein the glycol derivative comprises diethylene glycol dibenzoate.
